We occasionally use GnRH agonists in patients with a higher possibility of ovarian hyperstimulation syndrome as well as hCG in patients with a very low LH level during COH as they might not reactive to the GnRH agonist trigger. The gene discussed is PLOD1; the disease is ovarian hyperstimulation syndrome.